ArticlePloS one2015

Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity.

Robert G E Holgate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.